Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification

Tropical Medicine and International Health

Volumn 7, Issue 8, 2002, Pages 641-651

  Schallig, Henk D F H ^a   Oskam, Linda ^a  

^a ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

Control; Cutaneous; Diagnosis; Leishmania; Leishmaniasis; Molecular biology; Visceral

Indexed keywords

ANTIMONY; DNA VACCINE; PARASITE ANTIGEN; RECOMBINANT ANTIGEN;

BIOLOGICAL ANALYSIS; DRUG RESISTANCE; LEISHMANIASIS; PARASITE CONTROL;

ALLELE; AMASTIGOTE; DNA DETERMINATION; DNA MICROARRAY; DNA PROBE; DNA SEQUENCE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSED SEQUENCE TAG; GENE AMPLIFICATION; GENE EXPRESSION; GENOTYPE; HUMAN; LEISHMANIA; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE CONTROL; PARASITE IDENTIFICATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SCREENING; SERODIAGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN LEISHMANIASIS; SOUTHERN BLOTTING; TAXONOMY; VACCINATION;

ANIMALS; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MOLECULAR BIOLOGY;

LEISHMANIA MAJOR; PROTOZOA;

EID: 0036421832     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2002.00911.x     Document Type: Review

References (89)

1. Adhya S, Chatterjee M, Hassan MQ, Mukherjee S & Sen S (1995) Detection of Leishmania the blood of early kala-azar patients with the aid of the polymerase chain reaction. Transactions of the Royal Society for Tropical Medicine and Hygiene 89, 622-624.
2. Andresen K, Gaafar A, El-Hassan AM et al. (1996) Evaluation of the polymerase chain reaction in the diagnosis of cutaneous leishmaniasis due to Leishmania major: A comparison with direct microscopy of smears and sections from lesions. Transactions of the Royal Society for Tropical Medicine and Hygiene 90, 133-135.
3. Andresen K, Gasim S, Elhassan AM et al. (1997) Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan. Tropical Medicine and International Health 2, 440-444.
4. Anthony RM, Brown TJ & French GL (2001) DNA array technology and diagnostic microbiology. Expert Reviews on Molecular Diagnostics 1, 15-23.
5. Aviles H, Belli A, Armijos R, Monroy FP & Harris E (1999) PCR detection and identification of Leishmania parasites in clinical specimens in Ecuador: A comparison with classical diagnostic methods. Journal of Parasitology 85, 181-187.
6. Barker DC (1989) Molecular approaches to DNA diagnosis. Parasitology 99, S125-S146.
7. Ben Salah AB, Ben Ismail R, Amri F et al. (2000) Investigation of spread of human visceral leishmaniasis in central Tunisia. Transactions of the Royal Society for Tropical Medicine and Hygiene 94, 382-386.
8. Bretagne S, Durand R, Olivi M et al. (2001) Real-time PCR as a new tool for quantifying Leishmania infantum liver in infected mice. Clinical and Diagnostic Laboratory Immunology 8, 828-831.
9. Burns JM, Shreffler WG, Benson DR, Ghalib HW, Badaro R & Reed SG (1993) Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proceedings of the National Academy of Sciences of the USA 15, 775-779.
10. Campino L, Cortes S, Pires R, Oskam L & Abranches P (2000) Detection of Leishmania immunocompromised patients using peripheral blood spots on filter paper and the polymerase chain reaction. European Journal of Clinical Microbiology and Infectious Diseases 19, 396-398.
11. Compton J (1991) Nucleic acid sequence-based amplification. Nature 250, 91-92.
12. Croft SL (2001) Monitoring drug resistance in leishmaniasis. Tropical Medicine and International Health 6, 899-905.
13. Cupolillo E, Grimaldi G, Momen H & Beverly SM (1995) Intergenic region typing (IRT): a rapid molecular approach to the characterization and evaluation of Leishmania. Molecular and Biochemical Parasitology 73, 145-155.
14. Cupolillo E, Aguiar Alves F, Brahim LR et al. (2001) Recent advances in the taxonomy of the New World leishmanial parasites. Medical Microbiology and Immunology 190, 57-60.
15. Delgado O, Guevara P, Silva S, Belfort E & Ramirez JL (1996) Follow-up of a human accidental infection by Leishmania braziliensis using conventional immunologic techniques and polymerase chain reaction. American Journal for Tropical Medicine and Hygiene 55, 267-272.
16. Dey S, Ouellette M, Lightbody J, Papadopoulou B & Rosen BP (1996) An ATP-dependent As(III) -glutathione transport system in membrane vesicles of Leishmania tarentolae. Proceedings of the National Academy of Sciences of the USA 93, 2192-2197.
17. Dye C (1996) The logic of visceral leishmaniasis control. American Journal of Tropical Medicine and Hygiene 55, 125-130.
18. El Tai NO, El Fari M, Mauricio I et al. (2001) Leishmania donovani: Intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing. Experimental Parasitology 97, 35-44.
19. Gramiccia M, Smith DF, Angelici MC, Ready PD & Gradoni L (1992) A kinetoplast DNA probe diagnostic for Leishmania infantum. Parasitology 105, 29-34.
20. Grondin K, Haimeur A, Mukhopadyay R, Rosen BP & Oullette M (1997) Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA. arsenite-resistant Leishmania tarentolae. EMBO Journal 16, 3057-3065.
21. Guevara P, Rojas E, Gonzalez N et al. (1994) Presence of Leishmania braziliensis. Blood samples from cured patients or at different stages of immunotherapy. Clinical Diagnostic and Laboratory Immunology 1, 385-389.
22. Gurunathan S, Sacks DL, Brown DR et al. (1997) Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. Journal of Experimental Medicine 186, 1137-1147.
23. Gurunathan S, Wu C, Freidag BL & Seder RA (2000) DNA vaccines: A key for inducing long-term cellular immunity. Current Opinions in Immunology 12, 442-447.
24. Haimeur A, Brochu C, Genest P, Papadopoulou B & Oullette M (2000) Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae. Molecular and Biochemical Parasitology 108, 131-135.
25. Haimeur A, Guimond C, Pilote S et al. (1999) Elevated levels of polyamines and trypanothione resulting from overexpression of ornithine decarboxylase gene in arsenite-resistant Leishmania. Molecular Microbiology 34, 726-735.
26. Handman E (2001) Leishmaniasis: Current status of vaccine development. Clinical Microbiology Reviews 14, 229-243.
27. Hassan UA, Abai AM, Harper DR, Wren BW & Morrow WJ (1999) Nucleic acid immunization: Concepts and techniques associated with third generation vaccines. Journal of Immunological Methods 229, 1-22.
28. Houghton RL, Petrescu M, Benson DR et al. (1998) A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy. Journal of Infectious Diseases 177, 1339-1344.
29. Howard MK, Kelly JM, Lane RP & Miles MA (1991) A sensitive repetitive DNA probe that is specific to the Leishmania donovani complex and its use as an epidemiological and diagnostic reagent. Molecular and Biochemical Parasitology 44, 63-72.
30. Ivens AC & Blackwell JM (1999) The Leishmania genome comes of age. Parasitology Today 15, 225-231.
31. Jelinek T, Eichenlaub S & Loscher T (1999) Sensitivity and specificity of a rapid immunochromatographic test for diagnosis of visceral leishmaniasis. European Journal of Clinical Microbiology and Infectious Diseases 18, 669-670.
32. Katakura K, Kawazu SI, Sanjyoba C et al. (1998) Leishmania mini-exon genes for molecular epidemiology of leishmaniasis in China and Ecuador. Tokai Journal of Experimental Clinical Medicine 23, 393-399.
33. Klinman DM, Takeshita F, Kamstrup S et al. (2000) DNA vaccines: Capacity to induce auto-immunity and tolerance. Developmental Biology 104, 45-51.
34. Lachaud L, Dereure J, Chabbert E et al. (2000) Optimized PCR using patient blood samples for diagnosis and follow-up of visceral leishmaniasis, with special reference to AIDS patients. Journal of Clinical Microbiology 38, 236-240.
35. Lachaud L, Marchergui-Hammami S, Chabbert E, Dereure J, Dedet JP & Bastien P (2002) Comparison of six PCR methods using peripheral blood for detection of canine visceral leishmaniasis. Journal of Clinical Microbiology 40, 210-215.
36. Laskay T, Kiessling R, de Witt RTF & Wirth DF (1991) Generation of species-specific DNA probes for Leishmania aethiopica. Molecular and Biochemical Parasitology 44, 279-286.
37. Legare D, Cayer S, Singh AK, Richard D, Papadopoulou B & Oullette M (2001) ABC proteins of Leishmania. Journal of bioenergetics and Biomembranes 6, 469-474.
38. Longo MC, Berninger MS & Hartley JL (1990) Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reaction. Gene 93, 125-128.
39. Mathis A & Deplazes P (1995) PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. Journal of Clinical Microbiology 33, 1145-1149.
40. Mauricio IL, Stothard JR & Miles MA (2000) The strange case of Leishmania chagasi. Parasitology Today 16, 188-189.
41. McDonagh PD, Myler PJ & Stuart K (2000) The unusual gene organization of Leishmania major chromosome 1 may reflect novel transcription processes. Nucleic Acids Research 15, 2800-2803.
42. Melby PC, Yang J, Zhao W, Perez LE & Cheng J (2001) Leishmania donovani p36 (LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Infection and Immunity 69, 4719-4725.
43. Meredith SEO, Zijlstra EE, Schoone GJ et al. (1993) Development and application of the polymerase chain reaction for the detection and identification of Leishmania parasites in clinical material. Archives de L'Institut Pasteur de Tunis 70, 419-431.
44. Mor G & Eliza M (2001) Plasmid DNA vaccines. Immunology, tolerance and autoimmunity. Molecular Biotechnology 19, 245-250.
45. Morales MA, Chicharro C, Ares M, Canavate C, Barker DC & Alvar J (2001) Molecular tracking of infections by Leishmania infantum. Transactions of the Royal Society for Tropical Medicine and Hygiene 95, 104-107.
46. Myler PJ, Sisk E, McDonagh PD et al. (2000) Genomic organization and gene function in Leishmania. Biochemical Society Transactions 28, 527-531.
47. Myler PJ & Stuart KD (2000) Recent developments from the Leishmania genome project. Current Opinions in Microbiology 3, 412-416.
48. Noyes HA, Beli AA & Maingon R (1996) Appraisal of various random amplified polymorphic DNA-polymerase chain reaction primers for Leishmania identification. American Journal of Tropical Medicine and Hygiene 55, 98-105.
49. Nuzum E, White F, Thakur C et al. (1995) Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood. Journal of Infectious Diseases 171, 751-754.
50. Osman OF (1998) Visceral Leishmaniasis: The PCR and Direct Agglutination Test for Diagnosis and Management. PhD Thesis, University of Amsterdam, The Netherlands.
51. Osman OF, Oskam L, Zijlstra EE et al. (1997a) Evaluation of PCR for diagnosis of visceral leishmaniasis. Journal of Clinical Microbiology 35, 2454-2457.
52. Osman OF, Kager PA, Zijlstra EE, el-Hassan AM & Oskam L (1997b) Use of PCR on lymph-node samples as test of cure of visceral leishmaniasis. Annals of Tropical Medicine and Parasitology 91, 845-850.
53. Osman OF, Oskam L, Zijlstra EE, el-Hassan AM, el-Naeim DA & Kager PA (1998) Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment. Transactions of the Royal Society for Tropical Medicine and Hygiene 92, 397-400.
54. Ouellette M (2001) Biochemical and molecular mechanisms of drug resistance in parasites. Tropical Medicine and International Health 6, 874-882.
55. Ouellette M, Fase-Fowler F & Borst P (1990) The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO Journal 9, 1027-1033.
56. Piarroux R, Gamarelli F, Duman H et al. (1994) Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniasis in immunocompromised patients. Journal of Clinical Microbiology 32, 649-749.
57. Pirmez C, da Silva Trajano V, Paes-Oliveira Neto M et al. (1999) Use of PCR in diagnosis of human American tegumentary leishmaniasis in Rio de Janeiro, Brazil. Journal of Clinical Microbiology 37, 1819-1823.
58. Pizzuto M, Piazza M, Senese D et al. (2001) Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients co-infected with human immunodeficiency virus type 1. Journal of Clinical Microbiology 39, 357-361.
59. Pogue GP, Joshi M, Lee NS et al. (1996) Conservation of low-copy gene loci in Old World Leishmanias identifies mechanisms of parasite evolution and diagnostic markers. Molecular and Biochemical Parasitology 18, 27-40.
60. Qu JQ, Zhong L, Masoom-Yasinzai M et al. (1994) Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin. Transactions of the Royal Society for Tropical Medicine and Hygiene 88, 543-545.
61. Ramos A, Maslov DA, Fernandes O, Campbell DA & Simpson L (1996) Detection and identification of human pathogenic Leishmania and Trypanosoma species by hybridization of PCR-amplified mini-exon repeats. Experimental Parasitology 82, 242-250.
62. Reithinger R, Lambson BE, Barker DC & Davies CR (2000) Use of PCR to detect Leishmania (Viannia) spp. in dog blood and bone marrow. Journal of Clinical Microbiology 38, 748-751.
63. Rodriguez N, Rodriguez A, Cardona M, Barrios MA, McCann SH & Barker DC (2000) Leishmania (Viannia) guyanensis: A new minicricle class exclusive to this species isolated from a DNA cosmid library useful for taxonomic purposes. Experimental Parasitology 94, 143-149.
64. Salotra P, Sreenivas G, Pogue GP et al. (2001) Development of a species-specific PCR assay for detection of Leishmania donovani. Clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis. Journal of Clinical Microbiology 39, 849-854.
65. Schallig HDFH, Schoone GJ, Kroon CCM, Hailu A, Chappuis F & Veeken H (2001) Development and application of 'simple' diagnostic tools for visceral leishmaniasis. Medical Microbiology and Immunology 190, 69-71.
66. Schönian G, Schweynoch C, Zlateva K et al. (1996) Identification and determination of the relationships of species and strains within the genus Leishmania using single primers in the polymerase chain reaction. Molecular and Biochemical Parasitology 77, 19-29.
67. Schönian G, Schnur L, el Fari M et al. (2001) Genetic heterogenicity in the species Leishmania tropica revealed by different PCR-based methods. Transactions of the Royal Society for Tropical Medicine and Hygiene 95, 217-224.
68. Schoone GJ, Oskam L, Kroon NCM, Schallig HDFH & Omar SA (2000) Detection and quantification of Plasmodium falciparum. blood samples using quantitative nucleic acid sequence-based amplification. Journal of Clinical Microbiology 38, 4072-4075.
69. Schubach A, Haddad F & Oliveira-Neto MP (1998) Detection of leishmania DNA by polymerase chain reaction in scars of treated human patients. Journal of Infectious Diseases 178, 911-914.
70. Sereno D, Cavaleyra M, Zemzoumi K, Maquaire S, Ouissi A & Lemesre JL (1998) Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrobial Agents and Chemotherapy 42, 3097-3102.
71. Shaked-Mishan P, Ulrich N, Ephros M & Zilberstein D (2000) Novel intracellular Sb(V) reducing activity correlates with antimony susceptibility in Leishmania donovani. Journal of Biological Chemistry 276, 3971-3976.
72. Smith DF, Searle S, Ready PD, Gramiccia M & Ben-Ismail R (1989) A kinetoplast DNA probe diagnostic for Leishmania major: Sequence homologies between regions of Leishmania minicircles. Molecular and Biochemical Parasitology 37, 213-224.
73. Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Tropical Medicine and International Health 6, 849-854.
74. Sundar S, More DK, Singh MK et al. (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic. Clinical Infectious Diseases 31, 1104-1107.
75. Sunkin SM, Kiser P, Myler PJ & Stuart K (2000) The size difference between Leishmania major Friedlin chromosome one homologues is localized to sub-telomeric repeats at one chromosomal end. Molecular and Biochemical Parasitology 109, 1-15.
76. Tesh RB (1995) Control of zoonotic visceral leishmaniasis: Is it time to change strategies? American Journal of Tropical Medicine and Hygiene 52, 287-292.
77. Tibayrenc M & Ayala FJ (1999) Evolutionary genetics of Trypanosoma and Leishmania. Microbes and Infection 1, 465-472.
78. Tibayrenc M, Neubauer K, Barnabe C, Guerrini F, Skarecky D & Ayala FJ (1993) Genetic characterization of six parasitic protozoa: Parity between random-primer DNA typing and multilocus enzyme electrophoresis. Proceedings of the National Academy of Sciences of the USA 90, 1335-1339.
79. Ulmer JB, Sadoff JC & Liu MA (1996) DNA vaccines. Current Opinions in Immunology 8, 531-536.
80. Van Eys GJJM, Schoone GJ, Ligthart GS, Alvar J, Evans DA & Terpstra WJ (1989) Identification of Old World Leishmania by DNA recombinant probes. Molecular and Biochemical Parasitology 34, 53-62.
81. Van Eys GJJM, Guizani I, Ligthart GS & Dellagi K (1991) A nuclear probe for the identification of strains within the Leishmania donovani complex. Experimental Parasitology 72, 459-463.
82. Van Eys GJJM, Schoone GJ, Kroon NCM & Ebeling SB (1992) Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Molecular and Biochemical Parasitology 51, 133-142.
83. Veeken H (2001) Control of Infectious Disease in Developing Countries: Field Studies on Visceral Leishmaniasis and Meningitis. PhD Thesis, University of Amsterdam, The Netherlands.
84. Victoir K, Banuls AL, Arevalo J et al. (1998) The gp63 gene locus, a target for genetic characterization of Leishmania belonging to subgenus Viannia. Parasitology 117, 1-13.
85. Wahren B (1996) Gene vaccines. Immunotechnology 2, 77-83.
86. Walker PS, Scharton-Kersten T, Rowton ED et al. (1998) Genetic immunization with glycoprotein 63 cDNA results in a T helper cell type 1 response and protection in a murine model of leishmaniasis. Human Gene Therapy 9, 1899-1907.
87. Welsh J & McCleland M (1990) Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Research 18, 7213-7218.
88. World Health Organization (2000) Leishmania/HIV Co-Infection. WHO/LEISH/2000.42, Geneva.
89. Zijlstra EE, Nur Y, Desjeux P, Khalil EA, El-Hassan AM & Groen J (2001) Diagnosing visceral leishmaniasis with the recombinant K39 strip test: Experience from the Sudan. Tropical Medicine and International Health 6, 108-113.